Research articleA multimodality investigation of cerebral hemodynamics and autoregulation in pharmacological MRI
Introduction
Pharmacological MRI (phMRI) methods can be applied to assess the effects of acute drug challenge on cerebral hemodynamics as a surrogate for changes in the underlying neuronal activity. This approach has been widely applied to study central effects of drugs on the central nervous system (CNS) in humans and animal models [1], [2]. However, many of these drugs can also induce significant peripheral effects, including severe alterations of cardiovascular parameters. Under physiological conditions, mechanisms of autoregulation keep cerebral blood flow (CBF) relatively constant in the presence of changes in mean arterial blood pressure (MABP). However, general anesthetics, widely used in preclinical phMRI studies to avoid head motion and to better control animal physiology, may affect the central vasoadaptive response to peripheral MABP changes, thus making it difficult to predict the influence of systemic vasopressive effects on cerebral hemodynamics. Moreover, large and rapid changes in MABP may cause a breakdown in the autoregulatory mechanisms that control brain microcirculation, thus introducing potential confounds in the interpretation of phMRI data.
While blood-oxygen-level-dependent (BOLD) signals are most often measured in humans, relative cerebral blood volume (rCBV) has been widely used in phMRI studies in small laboratory animals due to the increased sensitivity afforded by rCBV measurements with intravascular contrast agents over BOLD [3]. However, dilation and constriction of cerebral blood vessels are thought to modulate vascular resistance in order to maintain CBF relatively constant in the presence of changes in perfusion pressure [4]. As a consequence, CBV might be sensitive to MABP changes even in the presence of intact autoregulation.
Several attempts to correlate the magnitude of systemic MABP changes with the central hemodynamic responses in the rodent brain have been published. Zaharchuk et al. [5] did not observe significant CBF, CBV or BOLD changes as MABP was gradually decreased (−1 mmHg/min) by continuous arterial blood withdrawal over the range of maximally effective autoregulation in the halothane-anesthetized rat. However, in a more recent study, Kalisch et al. [6] argued that slow and gradual decreases in MABP may not be representative of the abrupt changes typically observed in pharmacological MR experiments. Indeed, the same authors reported a significant correlation between BOLD signal time courses and MABP changes following rapid arterial blood withdrawal–reinfusion under three different anesthetic regimes in the rat (isoflurane, halothane and propofol). However, the use of the blood withdrawal–reinfusion method presents potential drawbacks such as the need to account for hemodilution, the risk of hemorrhagic shock-like complications and the lack of a stable and normotensive prestimulus MABP baseline.
Other investigators have measured the BOLD signal changes produced by pharmacologically evoked MABP alterations. Tuor et al. [7] and, more recently, Wang et al. [8] reported significant correlations between BOLD signal and the MABP changes induced by norepinephrine (NE), a non-brain-penetrant vasopressor, in rats anesthetized with α-chloralose. Luo et al. [9] observed significant fMRI responses under urethane anesthesia following acute challenge with cocaine but not with cocaine methiodide, a non-brain-penetrant cocaine analogue, at doses that increased MABP up to 180 mmHg, thus suggesting that potentially confounding peripheral effects were negligible in that specific protocol. However, the BOLD response may result from changes in several metabolic and hemodynamic parameters whose contributions cannot be easily disentangled, and these conclusions cannot be extended to phMRI methods based on rCBV measurements.
Here, we have applied laser Doppler flowmetry (LDF) and MRI to measure changes in CBF and microvascular CBV induced by increasing doses of an intravenous NE challenge in the halothane-anesthetized rat. The rCBV protocol employed has been used by us as well as by other groups to map the central hemodynamic response to a number of neuroactive compounds, including amphetamine [10], [11], [12], [13], cocaine [14], [15], apomorphine [16], [17] and nicotine [18], [19]. Following Tuor's approach, we explored increasing doses of NE in order to correlate the magnitude of the cardiovascular response with the corresponding changes in CBV, to assess the potentially confounding effects of MABP changes on CBV-based phMRI data. The use of a pharmacological vasopressor has the advantage of circumventing the limitations of the blood withdrawal and reinfusion method while reproducing the abrupt MABP changes that are typically observed upon drug injection. By measuring LDF changes, we were able to assess the integrity of CBF autoregulatory mechanisms in our model. The independent measurement of CBF and CBV enabled us to investigate the interplay of these two parameters in the range of effective vasoadaptive response and under autoregulation breakdown.
Section snippets
Animal preparation
All experiments were carried out in accordance with Italian regulations governing animal welfare and protection. Protocols were also reviewed and consented to by a local animal care committee, in accordance with the guidelines of the Principles of Laboratory Animal Care (NIH publication 86-23, revised 1985). These studies were performed on male Sprague–Dawley rats (250–350 g; Charles River, Como, Italy). Animals had free access to standard rat chow and tap water and were housed in groups of
Results
Intravenous administration of saline did not affect baseline MABP values. NE (0.125, 0.5, 2 and 8 μg/ml) produced fast-onset dose-dependent rises in MABP (98.1±5.5, 115.7±4.3, 141.2±6.8 and 159.8±5.9 mmHg at peak, respectively; Fig. 1A). At the three highest doses, the effect reached statistical significance (P<.0001 vs. saline, Fig. 1B). The changes were abrupt and short-lived, with return to preinjection baseline values typically within 5 min.
No significant changes in mean LDF were observed
Discussion and conclusion
Whether and how anesthesia affects cerebrovascular reactivity have been a contentious matter in recent literature. Results have often been inconsistent, possibly because blood flow autoregulation is sensitive to the specific experimental conditions of the study. The assessment of the effects of anesthesia on brain circulation is of pivotal importance in the context of phMRI, as several psychoactive drugs are known to induce profound cardiovascular effects. Here, we have independently measured
References (36)
- et al.
Human pharmacological MRI
Trends Pharmacol Sci
(2004) - et al.
Blood pressure changes induced by arterial blood withdrawal influence bold signal in anesthesized rats at 7 tesla: implications for pharmacologic MRI
Neuroimage
(2001) - et al.
Functional magnetic resonance imaging of tonic pain and vasopressor effects in rats
Magn Reson Imaging
(2002) - et al.
Transient blood pressure changes affect the functional magnetic resonance imaging detection of cerebral activation
Neuroimage
(2006) - et al.
Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI
Neuropharmacology
(2005) - et al.
Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration
Neuroimage
(2004) - et al.
Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in rat
Neuroimage
(2000) - et al.
A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: application to pharmacological MRI
Neuroimage
(2006) - et al.
Functional MRI using intravascular contrast agents: detrending of the relative cerebrovascular (rCBV) time course
Magn Reson Imaging
(2003) - et al.
Wavelet-based cluster analysis: data-driven grouping of voxel time courses with application to perfusion-weighted and pharmacological MRI of the rat brain
Neuroimage
(2005)
Pharmacological magnetic resonance imaging (phMRI)
Improved mapping of pharmacologically induced neuronal activation using the IRON technique with superparamagnetic blood pool agents
J Magn Reson Imaging
Autoregulation: arterial and intracranial pressure
Cerebrovascular dynamics of autoregulation and hypoperfusion. An MRI study of CBF and changes in total and microvascular cerebral blood volume during hemorrhagic hypotension
Stroke
Characterisation of effects of mean arterial blood pressure induced by cocaine and cocaine methiodide on BOLD signals in the rat brain
Magn Reson Med
Selective dopamine D(3) receptor antagonist SB-277011-A potentiates phMRI response to acute amphetamine challenge in the rat brain
Synapse
Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data
Magn Reson Med
Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI
Synapse
Cited by (59)
Functional networks and network perturbations in rodents
2017, NeuroImageImaging the accumulation and suppression of tau pathology using multiparametric MRI
2016, Neurobiology of AgingLarge-scale functional connectivity networks in the rodent brain
2016, NeuroImageFunctional connectivity hubs of the mouse brain
2015, NeuroImage